Non-white racial and ethnic groups are underrepresented in OB-GYN clinical trials, according to a new Northwestern Medicine study.
A Northwestern Medicine study has discovered that elevated PALI1 in advanced prostate tumors mediates crosstalk between two primary epigenetic silencing mechanisms, suggesting that dual epigenetic inhibition may be an effective therapeutic strategy.
The Breakthroughs podcast released more than 20 episodes in 2022 on topics ranging from the role of dopamine in habit formation to music-based medical interventions.
Investigators have developed a novel personalized T-cell therapy approach that may identify specific targets unique to a patient’s cancer cells more effectively than current treatments, according to findings published in Nature.
Daniel Martin Watterson, PhD, the John G. Searle Professor of Molecular Biology and Biochemistry, has been named a 2022 fellow of the National Academy of Inventors.
Northwestern Medicine scientists have identified a new therapeutic target against tumor cells and developed a compound which slows tumor growth and bolsters immune response.
Integrating social determinants of health helped mitigate bias when predicting long-term outcomes for heart failure patients, according to a Northwestern Medicine study.
Northwestern Medicine scientists have identified pathogenic variants in two genes linked to microcephaly and other neurodevelopmental disorders in children, according to a recent study published in Nature Communications.
A new Northwestern Medicine study has discovered the role of cerebrospinal fluid in cognitive impairment, such as Alzheimer’s disease.
In a new study, Northwestern investigators used artificial intelligence to analyze data from a wide variety of tissues, and discovered that the length of genes can explain most molecular-level changes that occur during aging.